🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

12 recruiting trials

for Drug-resistant Tuberculosis

Therapeutic Drug Monitoring for Linezolid in the Treatment of Rifampin-resistant Tuberculosis NCT06590428NA1 site📍 East London Albert Einstein College of Medicine · Tests: Therapeutic Drug Monitoring for Linezolid Training Protocol on the Natural History of Tuberculosis NCT01212003n/a1 site📍 Bethesda National Institute of Allergy and Infectious Diseases (NIAI… A Study of Quabodepistat-containing Regimens for the Treatment of Drug-resistant Pulmonary Tuberculosis NCT07209761Phase 342 sites📍 Beijing📍 Fuzhou📍 Shenzhen Otsuka Pharmaceutical Development & Commercialization, Inc. · Tests: Bedaquiline, Quabodepistat, Pretomanid, Moxifloxacin, Linezolid An Adaptive Randomized Controlled Trial NCT05633056NA1 site📍 Durban Columbia University · Tests: Adherence support intevention Bioneer Q-RFIA Clinical Evaluation NCT05117788n/a5 sites📍 Nairobi📍 Chisinau📍 Lima Foundation for Innovative New Diagnostics, Switzerland · Tests: Estimate the diagnostic accuracy of the Bioneer Accupower Q-RFIA PCR kit on IRON qPCR for MTB detection using culture a… Pragmatic Use of Next-generation Sequencing for Management of Drug-resistant Tuberculosis NCT05553236NA1 site📍 Cape Town University of California, San Francisco · Tests: Targeted next-generation sequencing A PAN-USR TB Multi-Center Trial NCT06905522Phase 33 sites📍 Beijing📍 Shenzhen📍 Ürümqi Shenzhen Third People's Hospital · Tests: Bedaquiline (B), Sitafloxacin (S), Linezolid (L), Pyrazinamide (Z), Isoniazid (H) Novel Triple-dose Tuberculosis Retreatment Regimen NCT04260477Phase 31 site📍 Niamey Institute of Tropical Medicine, Belgium · Tests: 6EH³R³Z, 6EHRZ Feasibility of the Application of a New Six-month Treatment for Multidrug-resistant Tuberculosis (MDR-TB) Patients in France (FAST-MDR) NCT07486024Phase 35 sites📍 Amiens📍 Paris📍 Paris Assistance Publique - Hôpitaux de Paris · Tests: Bedaquiline Oral Tablet, Bedaquiline Oral Tablet Linezolid Tolerance During the BPaL Regimen With Dosage Personalization Based on Therapeutic Drug Monitoring (TDM) During Multidrug-Resistant Tuberculosis Treatment NCT07477119Phase 41 site📍 Conakry Marco Schiuma · Tests: Linezolid dose personalization based on TDM Bring BPaL2Me Trial Comparing Nurse-Led RR-TB Treatment to Physician-Led RR-TB Treatment NCT05671718NA5 sites📍 Pietermaritzburg📍 Port Shepstone📍 East London Johns Hopkins University · Tests: Nurse-Led Treatment in Primary Care Program for Rifampicin-Resistant Disease With Stratified Medicine for Tuberculosis NCT06441006Phase 2, Phase 36 sites📍 Ulaanbaatar📍 Kotri📍 Lima University of California, San Francisco · Tests: Bedaquiline, Linezolid, Pretomanid, Moxifloxacin, Control Arm FQ-S MDR/RR-TB regimen, designed according to latest inte…
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy